Pharmacology of Adenosine Receptors: The State of the Art
Фармакология аденозиновых рецепторов: современное состояние
2018-05-31
SCID: 54.1/zrr4hmfu
Discuss with AI
adenosine receptorscancerdrug developmentneurodegenerative diseasesreceptor subtypes
Figures from the paper
Abstract (AI)
. Due to the rapid generation of adenosine from cellular metabolism, and the widespread distribution of its receptor subtypes in almost all organs and tissues, this nucleoside induces a multitude of physiopathological effects, regulating central nervous, cardiovascular, peripheral, and immune systems. It is becoming clear that the expression patterns of adenosine receptors vary among cell types, lending weight to the idea that they may be both markers of pathologies and useful targets for novel drugs. This review offers an overview of current knowledge on adenosine receptors, including their characteristic structural features, molecular interactions and cellular functions, as well as their essential roles in pain, cancer, and neurodegenerative, inflammatory, and autoimmune diseases. Finally, we highlight the latest findings on molecules capable of targeting adenosine receptors and report which stage of drug development they have reached.
Key Findings
1
Adenosine rapidly generated by cellular metabolism produces diverse physiological and pathological effects through widely distributed receptor subtypes.
2
Adenosine receptors have essential roles in pain, cancer, neurodegenerative, inflammatory, and autoimmune diseases.
3
Adenosine receptors regulate central nervous, cardiovascular, peripheral, and immune system functions.
4
Cell-type-specific adenosine receptor expression may enable their use as markers of pathology and targets for novel drugs.
5
The review summarizes receptor-targeting molecules and their progress through different stages of drug development.
Research Object
adenosine receptors
Research Subject
their structural features, molecular interactions, cellular functions, disease-related roles, and pharmacological targeting for drug development
Publication Details
Publication Date
2018-05-31
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest